You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab

Showing 1 - 25 of 636
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III, Melanoma Trial in Durham, Philadelphia (nivolumab, Ipilimumab)

Recruiting
  • Melanoma Stage III
  • Melanoma
  • Durham, North Carolina
  • +1 more
Mar 25, 2022

Melanoma Trial in Pittsburgh (drug, biological, other)

Recruiting
  • Melanoma
  • Vidutolimod (CMP-001)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 25, 2022

Muscle-Invasive Bladder Carcinoma Trial in Milan (Nivolumab + Nab-paclitaxel, Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Nivolumab + Nab-paclitaxel
  • Nivolumab
  • Milan, MI, Italy
    Genitourinary Medical Oncology - IRCCS San Raffaele Hospital and
Mar 28, 2022

Gastric Cancer, Chemo Effect Trial (Nivolumab plus SOX, Nivolumab, Gastrectomy)

Not yet recruiting
  • Gastric Cancer
  • Chemotherapy Effect
  • Nivolumab plus SOX
  • +2 more
  • (no location specified)
Jan 7, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Aug 19, 2022

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +1 more
Jun 2, 2022

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +2 more
Aug 15, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Esophageal Cancer Trial in Rotterdam (Nivolumab)

Not yet recruiting
  • Esophageal Cancer
  • Nivolumab
  • Rotterdam, Netherlands
    Erasmus MC
Aug 4, 2022

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Nivolumab
  • all trans retinoic acid
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low

Recruiting
  • NSCLC
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 28, 2022

Solid Tumors Trial in Guangzhou, Hangzhou (Nivolumab)

Completed
  • Solid Tumors
  • Nivolumab
  • Guangzhou, Guangdong, China
  • +1 more
Mar 14, 2022

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 16, 2022

Metastatic Melanoma Trial in Lancaster, Philadelphia (Hypofractionated Radiation Therapy (HFRT), Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Melanoma
  • Hypofractionated Radiation Therapy (HFRT)
  • +2 more
  • Lancaster, Pennsylvania
  • +1 more
Mar 30, 2022

Melanoma Trial in Philadelphia (Nivolumab, Hydroxychloroquine, Ipilimumab)

Recruiting
  • Melanoma
  • Nivolumab
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Sep 15, 2021

Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

Recruiting
  • Multiple Myeloma
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Apr 4, 2022

Breast Cancer Trial in Amsterdam (Nivolumab, Ipilimumab)

Recruiting
  • Breast Cancer
  • Amsterdam, Netherlands
    NKI-AVL
Mar 31, 2022

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Duarte (Nivolumab, Oral Azacitidine)

Recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Nivolumab
  • Oral Azacitidine
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)

Active, not recruiting
  • Refractory Central Nervous System Lymphoma
  • +2 more
  • Nivolumab
  • Hangzhou, Zhejiang, China
    Jianmin Zhang
Jul 3, 2022

Recurrent/Metastatic Carcinosarcoma Trial in Seoul (nivolumab)

Recruiting
  • Recurrent/Metastatic Carcinosarcoma
  • nivolumab
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Feb 3, 2022

Thyroid Cancer Trial in Boston (Nivolumab, Ipilimumab)

Active, not recruiting
  • Thyroid Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 18, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Prostate Cancer Trial run by the NCI (PROSTVAC-V/F, Nivolumab)

Recruiting
  • Prostate Cancer
  • PROSTVAC-V/F
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 12, 2022

Head Neck Cancer Trial in Houston (Nivolumab)

Not yet recruiting
  • Head and Neck Cancer
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022